PRESS RELEASE published on 09/18/2024 at 10:08, 1 year 4 months ago Franchissement de seuil Déclaration de franchissement de seuil par Mirova pour le compte de fonds qu'elle gère concernant MEDINCELL sur Euronext Paris Euronext Paris Franchissement De Seuil Gestion Medincell Mirova
BRIEF published on 09/11/2024 at 07:35, 1 year 5 months ago Medincell établit un nouveau contrat de liquidité avec Rothschild Martin Maurel Euronext Paris Contrat De Liquidité Rothschild Martin Maurel Actions Ordinaires Medincell
BRIEF published on 09/11/2024 at 07:35, 1 year 5 months ago Medincell establishes a new liquidity contract with Rothschild Martin Maurel Common Shares Euronext Paris Liquidity Contract Rothschild Martin Maurel Medincell
PRESS RELEASE published on 09/11/2024 at 07:30, 1 year 5 months ago Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité Medincell confie son Contrat de liquidité à ROTHSCHILD MARTIN MAUREL pour animer ses actions sur Euronext Paris, conformément à la réglementation en vigueur Euronext Paris Contrat De Liquidité Rothschild Martin Maurel Réglementation Medincell
PRESS RELEASE published on 09/11/2024 at 07:30, 1 year 5 months ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Medincell appoints ROTHSCHILD MARTIN MAUREL for liquidity contract management on Euronext Paris, complying with AMF Decision 2021-01 Euronext Paris Liquidity Contract Rothschild Martin Maurel AMF Decision Medincell
BRIEF published on 09/05/2024 at 07:35, 1 year 5 months ago Medincell : avancées prometteuses pour l'Olanzapine injectable Schizophrénie Phase 3 Medincell Olanzapine Teva Pharmaceuticals
BRIEF published on 09/05/2024 at 07:35, 1 year 5 months ago Medincell: Promising advances for injectable Olanzapine Schizophrenia Phase 3 Medincell Olanzapine Teva Pharmaceuticals
PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Teva, partenaire de Medincell, annonce des avancées importantes dans l'essai clinique pivot de phase 3 de l'Olanzapine injectable à durée d’action prolongée, avec un taux élevé d'injections réalisées et des résultats positifs attendus Schizophrénie Essai Clinique Medincell Olanzapine Teva
PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases Teva provides update on pivotal Phase 3 of Olanzapine LAI by Medincell. Safety results on track for H2 2024. Potential innovative long-acting antipsychotic treatment Clinical Trials Phase 3 Medincell Teva Olanzapine LAI
BRIEF published on 08/20/2024 at 17:52, 1 year 5 months ago Modalités de participation à l’Assemblée Générale de Medincell Actionnaires Assemblée Générale Vote À Distance Medincell Videoconference
Published on 02/14/2026 at 01:00, 1 day 8 hours ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 1 day 10 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 15 hours ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 18 hours ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 16:30, 16 hours 41 minutes ago Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 1 day 3 hours ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 1 day 13 hours ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 1 day 14 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 1 day 14 hours ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:05, 1 day 15 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 15 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 15 hours ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 15 hours ago Nombre total d'actions et droits de vote - janvier 2026
